Perspective Therapeutics Files 8-K
Ticker: CATX · Form: 8-K · Filed: Jul 3, 2025 · CIK: 728387
Sentiment: neutral
Topics: 8-K, corporate-filing, financials
TL;DR
Perspective Therapeutics (formerly Isoray) filed an 8-K on July 3rd. Standard reporting.
AI Summary
Perspective Therapeutics, Inc. filed an 8-K on July 3, 2025, reporting other events and financial statements. The company, formerly known as Isoray, Inc., is incorporated in Delaware and headquartered in Seattle, Washington.
Why It Matters
This filing indicates routine corporate reporting, including financial statements and other events, which is important for investors to stay updated on the company's status.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for corporate reporting and does not appear to contain any significant new risks or material events.
Key Numbers
- 001-33407 — Commission File Number (Identifier for SEC filings)
- 41-1458152 — IRS Employer Identification No. (Tax identification number)
Key Players & Entities
- Perspective Therapeutics, Inc. (company) — Registrant
- Isoray, Inc. (company) — Former company name
- July 03, 2025 (date) — Date of earliest event reported
- Seattle, Washington (location) — Principal Executive Offices
FAQ
What specific 'Other Events' are being reported in this 8-K filing?
The filing indicates 'Other Events' as an item information, but the specific details of these events are not provided in the provided text excerpt.
When was Perspective Therapeutics, Inc. formerly known as Isoray, Inc.?
The filing indicates that the former company name was Isoray, Inc. with a date of name change of 20181231.
What is the principal executive office address for Perspective Therapeutics, Inc.?
The principal executive offices are located at 2401 Elliott Avenue, Suite 320, Seattle, Washington 98121.
What is the Standard Industrial Classification (SIC) code for Perspective Therapeutics, Inc.?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What is the fiscal year end for Perspective Therapeutics, Inc.?
The fiscal year end for the company is December 31 (1231).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 3, 2025 regarding Perspective Therapeutics, Inc. (CATX).